Hematologic disorders comprise a vast category of diseases that affect millions of Americans and have a significant impact on the lives of individuals, their loved ones and the U.S. healthcare system ...

Hematologic malignancy patients face high COVID-19 risk, with 23.5% experiencing severe illness despite vaccination. Mortality rate was 22.4%, influenced by age, active disease, and ICU admission.

The US Food and Drug Administration (FDA) on Thursday finalized guidance on the nonclinical studies drugmakers should conduct when developing products to treat severely debilitating or ...

Hematopoietic Stem-Cell Transplantation: Exploring the Latest Advances and Gaps in Disparities, Psychosocial and Symptom Management Interventions, and Chronic Graft-Versus-Host Disease Care Although ...

A new report in The Lancet Haematology, led by Cleveland Clinic hematologist Bethany Samuelson Bannow, M.D., outlines ...

A new report in The Lancet Haematology, led by Cleveland Clinic hematologist Bethany Samuelson Bannow, M.D., outlines practical strategies to improve diagnosis, care and outcomes globally for women ...

Early longitudinal specialist-delivered inpatient palliative care for patients with AML and those undergoing HSCT has been shown to decrease anxiety, depression, and post traumatic stress disorder ...

Announcing a new article publication for Zoonoses journal. Hematologic disorders occur frequently in patients with Ebola virus disease (EVD) and are characterized by one or several abnormalities in ...

Hematology oncology is a medical specialty concerned with diagnosing and treating blood, bone marrow, and lymphatic system cancers such as leukemia and lymphoma. It is sometimes also referred to as ...

It will serve as a flagship hub for diagnosis, amongst others. The Department of Health – Abu Dhabi (DOH), AstraZeneca and ...